Psych News Alert | schizophrenia (4)

LAI Antipsychotics Associated With Diminishing Risk of Relapse but Risk Remains High

2/20/25, 12:00 AM

Study Finds Clozapine Is Most Effective Option for Preventing Second Psychosis Relapse

1/24/25, 12:00 AM

New Schizophrenia Drug Shows Marked Effect on Cognitive Deficits

12/11/24, 12:00 AM

FDA Panel Votes 14-1 Against Clozapine REMS

11/20/24, 12:00 AM

For Coordinated Specialty Care, Fidelity to Program Components Matters

11/19/24, 12:00 AM

Hallucinogen-Related ED Visits Associated With Schizophrenia Risk

11/14/24, 12:00 AM

Many Patients With Schizophrenia Benefit From Guided Antipsychotic Tapering Program

10/22/24, 12:00 AM

FDA Approves Cobenfy, Antipsychotic With a New Approach to Schizophrenia

9/27/24, 12:00 AM

Continuation, Maintenance ECT Lower Risk of Readmission After Acute ECT

9/20/24, 12:00 AM